checkAd

     959  0 Kommentare New England Journal of Medicine Publishes New Analyses Confirming that Sanofi Pasteur's Vaccine Candidate Safely Protects Pre-Adolescents to Adults Against Dengue - Seite 5


    Contacts:
              		 
    Global Media Relations
      
    Alain Bernal 
    T. +33 (0) 4 37 37 50 38 
    alain.bernal@sanofipasteur.com   
    www.sanofipasteur.com     		Sanofi Investor Relations 
     
     Sébastien Martel 
    T. + 33 (0) 1 53 77 45 45
    ir@sanofi.com 


    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: Sanofi via Globenewswire

    Lesen Sie auch

    HUG#1940753
    Seite 5 von 5



    Diskutieren Sie über die enthaltenen Werte



    GlobeNewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Verfasst von GlobeNewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    New England Journal of Medicine Publishes New Analyses Confirming that Sanofi Pasteur's Vaccine Candidate Safely Protects Pre-Adolescents to Adults Against Dengue - Seite 5 New England Journal of Medicine Publishes New Analyses Confirming that Sanofi Pasteur's Vaccine Candidate Safely Protects Pre-Adolescents to Adults Against Dengue - The highest burden of dengue disease globally in endemic countries is in …

    Artikel zu den Werten

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer